91Ó°ÊÓ

Biostatistics is a branch of statistics that applies statistical methods to biological and health sciences. It involves designing studies and analyzing data from experiments, clinical trials, and other forms of research. Biostatisticians help answer critical questions in medical and health research through statistical analysis.

In our exercise, biostatistics is applied to compare recurrence-free survival rates between two groups: patients receiving a drug and those receiving a placebo. By systematically recording and analyzing these rates, researchers can draw conclusions about the drug's effectiveness. This approach ensures that findings are not due to chance but are statistically backed.

• **Design of Study**: Randomized, double-blind trials are used to increase reliability. This design minimizes the bias, allowing for objective comparison.
• **Data Analysis**: Biostatisticians use tools like hypothesis testing and confidence intervals to interpret study results, thus assessing the effect size and relevance of the findings.

Proportions in statistics refer to the fraction of the whole or percentage of a given set that exhibits a particular characteristic. In the study described, proportions are used to compare the percentage of patients experiencing recurrence-free survival between the drug and placebo groups.

The basic formula to calculate a proportion is \[\text{Proportion} = \frac{\text{Number of successes}}{\text{Total number in the group}} \]To express it as a percentage, simply multiply by 100.

In the exercise, we computed two proportions:

• Proportion of recurrence-free survival in the drug group: \(\frac{388}{514} \times 100\%\)
• Proportion of recurrence-free survival in the placebo group: \(\frac{308}{505} \times 100\%\)

Understanding proportions allows researchers to determine whether the drug provides a better outcome compared to the placebo. Proportions help to easily communicate the effectiveness of the treatments in percentages, which are more intuitive.

Significance level, represented by \(\alpha\), is a threshold set by researchers to determine the cutoff for rejecting the null hypothesis in hypothesis testing. It quantifies the risk of concluding that there is an effect when there is none—a Type I error.

A commonly used significance level is 0.05. In the context of our study, after performing a hypothesis test comparing survival proportions, this level will guide whether the observed difference is statistically significant.

• **Null Hypothesis (H0)**: Assumes no difference in recurrence-free survival between the two groups. Researchers aim to reject this hypothesis to support the alternative.
• **Alternative Hypothesis (Ha)**: Proposes that the drug group actually has a higher proportion of recurrence-free survivors.
• **Decision Rule**: If the p-value from the test is less than 0.05, it suggests the observed data would be unusual under the null hypothesis, leading to its rejection.

Understanding the concept of significance levels helps interpret research findings correctly. It adds rigor to the study, ensuring that conclusions drawn are valid within the established statistical framework.